• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CYT
Click for more information
0.00% 13.0¢

CYTOPIA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CYTRemoval from Official List05/02/10
CYTImplementation of merger with YM BioSciences01/02/10
CYTChange of Director's Interest Notice19/01/10
CYTSuspension from Official QuotationPRICE SENSITIVE18/01/10
CYTScheme of Arrangement - Lodgement of Court Orders18/01/10
CYTCourt approval of Scheme of Arrangement15/01/10
CYTASX Circular - Merger with YM Biosciences Inc12/01/10
CYTResults of Scheme Meeting12/01/10
CYTResults of 2009 Annual General Meeting12/01/10
CYTScheme Meeting - Chairman's Address12/01/10
CYTCytopia 2009 AGM - Chariman and CEO's address12/01/10
CYTProposed Merger with YM BioSciences - Update07/01/10
CYTCytopia Proposed Merger with YM - Frequently Asked Questions05/01/10
CYTBecoming a substantial holder29/12/09
CYTBecoming a substantial holder22/12/09
CYTYM BioSciences Merger - Supplementary Information18/12/09
CYTCytopia Proposed Merger Presentation18/12/09
CYTNew Date for 2009 Annual General Meeting11/12/09
CYTScheme Meeting for proposed merger with YM Biosciences09/12/09
CYTDosing in Cytopia's CYT387 clinical trial beginsPRICE SENSITIVE24/11/09
CYTNotice of Annual General Meeting/Proxy Form19/11/09
CYTCytopia releases data on novel VDA CYT99710/11/09
CYTUpdate on Merger with YM BioSciencesPRICE SENSITIVE02/11/09
CYTChange of Company Address30/10/09
CYTAnnual Report to shareholders30/10/09
CYTFinal Director's Interest Notice23/10/09
CYTCytopia opens fourth clinical centre for CYT997 glioma studyPRICE SENSITIVE19/10/09
CYTDirector Resignation19/10/09
CYTCytopia merger with YM BioSciences IncPRICE SENSITIVE06/10/09
CYTCytopia achieves grant of further patent for JAK2 programPRICE SENSITIVE30/09/09
CYTFull Year Statutory Accounts17/09/09
CYTCYT387 receives FDA clearance to start US clinical trialsPRICE SENSITIVE04/09/09
CYTPreliminary Final ReportPRICE SENSITIVE25/08/09
CYTNewsletter August 2009 Edition21/08/09
CYTChange in substantial holding02/07/09
CYTChange in substantial holding29/06/09
CYTCytopia lodges IND for JAK2 inhibitor CYT387PRICE SENSITIVE23/06/09
CYTCytopia secures key patentsPRICE SENSITIVE16/06/09
CYTCytopia Moves Focus to Clinical Stage Cancer CompanyPRICE SENSITIVE05/06/09
CYTCYT997 Phase I Clinical Trial Presentation at ASCO29/05/09
CYTCancer Program Reaches Important MilestonePRICE SENSITIVE26/05/09
CYTNewsletter April 2009 Edition20/04/09
CYTCytopia presentation on VDA CYT997 at AACR conference16/04/09
CYTProtein structure involved in immune system/cancer solvedPRICE SENSITIVE24/03/09
CYTJAK2 presentation at American Chemical Society Conference24/03/09
CYTBecoming a substantial holder12/03/09
CYT +Cytopia starts court proceedings to prevent merger meeting05/03/09
AVX +Avexa letter to Progen shareholders02/03/09
AVX +Urge to REJECT Cytopia's call to adjourn Merger Meeting02/03/09
CYT +Letter to Shareholders25/02/09
CYT +Progen concedes shareholder requisitioned meeting19/02/09
CYT +Progen Schedules Requisitioned Meeting of Shareholders18/02/09
AVX +Response to inaccurate statement11/02/09
AVX +CYT and other PGL shareholders maintain call for meeting09/02/09
CYTHalf Yearly Report and AccountsPRICE SENSITIVE09/02/09
CYT +Progen-Avexa Merger Chairman's Letter to Shareholders05/02/09
AVX +Progen Reaction to Requisition for General Meeting05/02/09
CYTCytopia Concludes Phase I Oral Trial for CYT997PRICE SENSITIVE05/02/09
CYT +Response to Requisitioned General Meeting28/01/09
CYT +Request for General Meeting of Progen Pharmaceuticals Ltd28/01/09
CYTNewsletter December 2008 Edition18/12/08
CYTPresentation on JAK2 Inhibitor Program in MPDs08/12/08
CYTAppendix 3B26/11/08
CYTResults of Meeting20/11/08
CYTChairman and Managing Director Addresses at AGM20/11/08
CYTRemoval from Official List
05/02/10
CYTImplementation of merger with YM BioSciences
01/02/10
CYTChange of Director's Interest Notice
19/01/10
CYTSuspension from Official Quotation
18/01/10PRICE SENSITIVE
CYTScheme of Arrangement - Lodgement of Court Orders
18/01/10
CYTCourt approval of Scheme of Arrangement
15/01/10
CYTASX Circular - Merger with YM Biosciences Inc
12/01/10
CYTResults of Scheme Meeting
12/01/10
CYTResults of 2009 Annual General Meeting
12/01/10
CYTScheme Meeting - Chairman's Address
12/01/10
CYTCytopia 2009 AGM - Chariman and CEO's address
12/01/10
CYTProposed Merger with YM BioSciences - Update
07/01/10
CYTCytopia Proposed Merger with YM - Frequently Asked Questions
05/01/10
CYTBecoming a substantial holder
29/12/09
CYTBecoming a substantial holder
22/12/09
CYTYM BioSciences Merger - Supplementary Information
18/12/09
CYTCytopia Proposed Merger Presentation
18/12/09
CYTNew Date for 2009 Annual General Meeting
11/12/09
CYTScheme Meeting for proposed merger with YM Biosciences
09/12/09
CYTDosing in Cytopia's CYT387 clinical trial begins
24/11/09PRICE SENSITIVE
CYTNotice of Annual General Meeting/Proxy Form
19/11/09
CYTCytopia releases data on novel VDA CYT997
10/11/09
CYTUpdate on Merger with YM BioSciences
02/11/09PRICE SENSITIVE
CYTChange of Company Address
30/10/09
CYTAnnual Report to shareholders
30/10/09
CYTFinal Director's Interest Notice
23/10/09
CYTCytopia opens fourth clinical centre for CYT997 glioma study
19/10/09PRICE SENSITIVE
CYTDirector Resignation
19/10/09
CYTCytopia merger with YM BioSciences Inc
06/10/09PRICE SENSITIVE
CYTCytopia achieves grant of further patent for JAK2 program
30/09/09PRICE SENSITIVE
CYTFull Year Statutory Accounts
17/09/09
CYTCYT387 receives FDA clearance to start US clinical trials
04/09/09PRICE SENSITIVE
CYTPreliminary Final Report
25/08/09PRICE SENSITIVE
CYTNewsletter August 2009 Edition
21/08/09
CYTChange in substantial holding
02/07/09
CYTChange in substantial holding
29/06/09
CYTCytopia lodges IND for JAK2 inhibitor CYT387
23/06/09PRICE SENSITIVE
CYTCytopia secures key patents
16/06/09PRICE SENSITIVE
CYTCytopia Moves Focus to Clinical Stage Cancer Company
05/06/09PRICE SENSITIVE
CYTCYT997 Phase I Clinical Trial Presentation at ASCO
29/05/09
CYTCancer Program Reaches Important Milestone
26/05/09PRICE SENSITIVE
CYTNewsletter April 2009 Edition
20/04/09
CYTCytopia presentation on VDA CYT997 at AACR conference
16/04/09
CYTProtein structure involved in immune system/cancer solved
24/03/09PRICE SENSITIVE
CYTJAK2 presentation at American Chemical Society Conference
24/03/09
CYTBecoming a substantial holder
12/03/09
CYT +Cytopia starts court proceedings to prevent merger meeting
05/03/09
AVX +Avexa letter to Progen shareholders
02/03/09
AVX +Urge to REJECT Cytopia's call to adjourn Merger Meeting
02/03/09
CYT +Letter to Shareholders
25/02/09
CYT +Progen concedes shareholder requisitioned meeting
19/02/09
CYT +Progen Schedules Requisitioned Meeting of Shareholders
18/02/09
AVX +Response to inaccurate statement
11/02/09
AVX +CYT and other PGL shareholders maintain call for meeting
09/02/09
CYTHalf Yearly Report and Accounts
09/02/09PRICE SENSITIVE
CYT +Progen-Avexa Merger Chairman's Letter to Shareholders
05/02/09
AVX +Progen Reaction to Requisition for General Meeting
05/02/09
CYTCytopia Concludes Phase I Oral Trial for CYT997
05/02/09PRICE SENSITIVE
CYT +Response to Requisitioned General Meeting
28/01/09
CYT +Request for General Meeting of Progen Pharmaceuticals Ltd
28/01/09
CYTNewsletter December 2008 Edition
18/12/08
CYTPresentation on JAK2 Inhibitor Program in MPDs
08/12/08
CYTAppendix 3B
26/11/08
CYTResults of Meeting
20/11/08
CYTChairman and Managing Director Addresses at AGM
20/11/08
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.